Cure8 research brief
This large, population-based study tests whether exposure to outdoor artificial light at night is linked to getting IBD or to later health-care use. Understanding environmental factors that might influence IBD risk or disease course could help guide future research into prevention or management.
Adult patients with IBD or newly diagnosed IBD, clinicians who follow IBD patients, and researchers studying environmental risk factors for IBD.
This population-based study from Ontario examined outdoor artificial light at night (ALAN) and several IBD outcomes using linked administrative data.
Researchers used multiple observational designs (birth cohort, matched case-control, and cohort analyses) and categorized ALAN into three levels to test associations with IBD incidence, surgery, and health-service use. They found no clear association between ALAN at birth and later IBD in the birth-cohort analysis.
In the matched case-control analysis, higher ALAN was associated with a slightly lower odds of having IBD. Higher ALAN was also linked to modestly fewer IBD-specific outpatient visits and hospitalizations in the year after diagnosis, but ALAN was not associated with surgery or emergency visits.
The authors conclude the relationship between outdoor ALAN and IBD is heterogeneous and that further research is needed to clarify mechanisms and other environmental contributors. This summary is grounded in the article abstract and structured summary provided by the journal (abstract-level content).
Findings come from observational administrative-data analyses and the article abstract; associations do not prove causation. The summary is based on the published abstract (abstract-level content) and does not reflect review of the full article text beyond that abstract.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Canadian Institutes of Health Research
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Shows real-world long-term outcomes in a large Chinese UC cohort and highlights that baseline disease activity predicts need for escalation and colectomy risk; points to opportunities to improve treat-to-target care.
A coordinated national research network can accelerate studies that matter to people with IBD—like tracking real-world disease patterns, testing diet and psychosocial approaches, improving monitoring with biomarkers and...
This study synthesizes randomized trial evidence about the role of gut microbiota in ulcerative colitis and whether fecal microbiota transplantation (FMT) can help induce remission. People with UC may encounter FMT as a...
